IMNM Chart
- 52-Week Range: $2.24 - $27.76
- Market Capitalization: $34.44M
- Short Percentage: 0%
- Target Price: $11.50
- Shares Outstanding: 12.13M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
IMNM released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- FDA Lifts Clinical Hold on Immunome's IMM-BCP-01 IND Application for the Treatment of COVID-19Business Wire | March 11th
- Immunome to Participate in Fireside Chat Hosted by Cantor FitzgeraldBusiness Wire | December 7th
- Immunome to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech SummitBusiness Wire | September 15th
- Immunome to Present at the Ladenburg Thalmann 2021 Healthcare ConferenceBusiness Wire | July 6th
Company Info
Website: https://immunome.com
Address: 665 Stockton Drive, Exton, PA, United States, 19341
Sector: Healthcare
Industry: Biotechnology
Full time employees: 39
Address: 665 Stockton Drive, Exton, PA, United States, 19341
Sector: Healthcare
Industry: Biotechnology
Full time employees: 39
$IMNM I REALLY THINK WE FINALLY HAVE OUR FIRESALE?? !!
$IMNM holdddd it tight yall
$IMNM has just been halted from trading due to volatility.
$IMNM hot trash
$IMNM do what the markets tells you to do not the other way around
$IMNM Looks like a solid reversal - retesting support right now
definitely thinking about swinging this
$IMNM let’s buy NOW!!!
$IMNM omg lol
$IMNM all in
$IMNM Good night bears!